Bio Techne Earnings Estimate
| TECH Stock | USD 72.76 0.93 1.29% |
Bio Techne Revenue Breakdown by Earning Segment
By analyzing Bio Techne's earnings estimates, investors can diagnose different trends across Bio Techne's analyst sentiment over time as well as compare current estimates against different timeframes. As of now, Bio Techne's Net Profit Margin is decreasing as compared to previous years.
Bio |
Bio Techne Earnings Estimation Breakdown
The calculation of Bio Techne's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bio Techne is estimated to be 0.3853 with the future projection ranging from a low of 0.36 to a high of 0.4041. Please be aware that this consensus of annual earnings estimates for Bio Techne Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.36 Lowest | Expected EPS | 0.40 Highest |
Bio Techne Earnings Projection Consensus
Suppose the current estimates of Bio Techne's value are higher than the current market price of the Bio Techne stock. In this case, investors may conclude that Bio Techne is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bio Techne's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 15 | 90.94% | 0.42 | 0.3853 | 0.95 |
Bio Techne Earnings History
Earnings estimate consensus by Bio Techne Corp analysts from Wall Street is used by the market to judge Bio Techne's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Bio Techne's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Bio Techne Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne Earnings per Share Projection vs Actual
Actual Earning per Share of Bio Techne refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bio Techne Corp predict the company's earnings will be in the future. The higher the earnings per share of Bio Techne, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Bio Techne Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Bio Techne, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bio Techne should always be considered in relation to other companies to make a more educated investment decision.Bio Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Bio Techne's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-30 | 2024-09-30 | 0.38 | 0.42 | 0.04 | 10 | ||
2024-08-07 | 2024-06-30 | 0.49 | 0.49 | 0.0 | 0 | ||
2024-05-01 | 2024-03-31 | 0.45 | 0.48 | 0.03 | 6 | ||
2024-02-01 | 2023-12-31 | 0.41 | 0.4 | -0.01 | 2 | ||
2023-10-31 | 2023-09-30 | 0.44 | 0.41 | -0.03 | 6 | ||
2023-08-08 | 2023-06-30 | 0.55 | 0.55 | 0.0 | 0 | ||
2023-05-03 | 2023-03-31 | 0.53 | 0.53 | 0.0 | 0 | ||
2023-02-02 | 2022-12-31 | 0.62 | 0.47 | -0.15 | 24 | ||
2022-11-01 | 2022-09-30 | 0.59 | 0.45 | -0.14 | 23 | ||
2022-08-04 | 2022-06-30 | 0.52 | 0.51 | -0.01 | 1 | ||
2022-05-04 | 2022-03-31 | 0.5 | 0.54 | 0.04 | 8 | ||
2022-02-01 | 2021-12-31 | 0.45 | 0.47 | 0.02 | 4 | ||
2021-11-02 | 2021-09-30 | 0.43 | 0.46 | 0.03 | 6 | ||
2021-08-05 | 2021-06-30 | 0.43 | 0.47 | 0.04 | 9 | ||
2021-05-06 | 2021-03-31 | 0.39 | 0.45 | 0.06 | 15 | ||
2021-02-02 | 2020-12-31 | 0.34 | 0.41 | 0.07 | 20 | ||
2020-11-05 | 2020-09-30 | 0.27 | 0.36 | 0.09 | 33 | ||
2020-08-04 | 2020-06-30 | 0.19 | 0.25 | 0.06 | 31 | ||
2020-04-30 | 2020-03-31 | 0.29 | 0.35 | 0.06 | 20 | ||
2020-02-04 | 2019-12-31 | 0.28 | 0.27 | -0.01 | 3 | ||
2019-10-29 | 2019-09-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2019-08-06 | 2019-06-30 | 0.33 | 0.31 | -0.02 | 6 | ||
2019-04-30 | 2019-03-31 | 0.29 | 0.3 | 0.01 | 3 | ||
2019-02-05 | 2018-12-31 | 0.25 | 0.27 | 0.02 | 8 | ||
2018-10-30 | 2018-09-30 | 0.24 | 0.25 | 0.01 | 4 | ||
2018-08-07 | 2018-06-30 | 0.32 | 0.34 | 0.02 | 6 | ||
2018-05-02 | 2018-03-31 | 0.29 | 0.3 | 0.01 | 3 | ||
2018-02-06 | 2017-12-31 | 0.23 | 0.26 | 0.03 | 13 | ||
2017-10-31 | 2017-09-30 | 0.22 | 0.23 | 0.01 | 4 | ||
2017-08-08 | 2017-06-30 | 0.25 | 0.27 | 0.02 | 8 | ||
2017-05-02 | 2017-03-31 | 0.23 | 0.24 | 0.01 | 4 | ||
2017-02-07 | 2016-12-31 | 0.21 | 0.2 | -0.01 | 4 | ||
2016-10-31 | 2016-09-30 | 0.2 | 0.21 | 0.01 | 5 | ||
2016-08-17 | 2016-06-30 | 0.24 | 0.23 | -0.01 | 4 | ||
2016-05-03 | 2016-03-31 | 0.22 | 0.25 | 0.03 | 13 | ||
2016-02-02 | 2015-12-31 | 0.21 | 0.22 | 0.01 | 4 | ||
2015-10-28 | 2015-09-30 | 0.21 | 0.2 | -0.01 | 4 | ||
2015-08-06 | 2015-06-30 | 0.22 | 0.22 | 0.0 | 0 | ||
2015-05-05 | 2015-03-31 | 0.23 | 0.22 | -0.01 | 4 | ||
2015-02-03 | 2014-12-31 | 0.21 | 0.21 | 0.0 | 0 | ||
2014-10-28 | 2014-09-30 | 0.22 | 0.21 | -0.01 | 4 | ||
2014-08-11 | 2014-06-30 | 0.21 | 0.22 | 0.01 | 4 | ||
2014-04-28 | 2014-03-31 | 0.22 | 0.24 | 0.02 | 9 | ||
2014-02-04 | 2013-12-31 | 0.2 | 0.19 | -0.01 | 5 | ||
2013-10-29 | 2013-09-30 | 0.2 | 0.21 | 0.01 | 5 | ||
2013-08-06 | 2013-06-30 | 0.21 | 0.21 | 0.0 | 0 | ||
2013-04-30 | 2013-03-31 | 0.22 | 0.22 | 0.0 | 0 | ||
2013-02-05 | 2012-12-31 | 0.19 | 0.19 | 0.0 | 0 | ||
2012-10-23 | 2012-09-30 | 0.2 | 0.19 | -0.01 | 5 | ||
2012-07-31 | 2012-06-30 | 0.21 | 0.2 | -0.01 | 4 | ||
2012-05-01 | 2012-03-31 | 0.22 | 0.23 | 0.01 | 4 | ||
2012-01-31 | 2011-12-31 | 0.2 | 0.19 | -0.01 | 5 | ||
2011-10-25 | 2011-09-30 | 0.21 | 0.2 | -0.01 | 4 | ||
2011-08-02 | 2011-06-30 | 0.19 | 0.21 | 0.02 | 10 | ||
2011-05-03 | 2011-03-31 | 0.2 | 0.21 | 0.01 | 5 | ||
2011-02-01 | 2010-12-31 | 0.17 | 0.17 | 0.0 | 0 | ||
2010-10-26 | 2010-09-30 | 0.18 | 0.18 | 0.0 | 0 | ||
2010-08-03 | 2010-06-30 | 0.18 | 0.17 | -0.01 | 5 | ||
2010-05-04 | 2010-03-31 | 0.2 | 0.19 | -0.01 | 5 | ||
2010-02-02 | 2009-12-31 | 0.17 | 0.17 | 0.0 | 0 | ||
2009-10-28 | 2009-09-30 | 0.18 | 0.18 | 0.0 | 0 | ||
2009-08-04 | 2009-06-30 | 0.17 | 0.17 | 0.0 | 0 | ||
2009-04-28 | 2009-03-31 | 0.18 | 0.19 | 0.01 | 5 | ||
2009-02-03 | 2008-12-31 | 0.16 | 0.16 | 0.0 | 0 | ||
2008-10-22 | 2008-09-30 | 0.16 | 0.19 | 0.03 | 18 | ||
2008-08-05 | 2008-06-30 | 0.17 | 0.18 | 0.01 | 5 | ||
2008-04-29 | 2008-03-31 | 0.17 | 0.19 | 0.02 | 11 | ||
2008-01-29 | 2007-12-31 | 0.14 | 0.15 | 0.01 | 7 | ||
2007-10-24 | 2007-09-30 | 0.14 | 0.14 | 0.0 | 0 | ||
2007-08-07 | 2007-06-30 | 0.14 | 0.14 | 0.0 | 0 | ||
2007-05-01 | 2007-03-31 | 0.15 | 0.15 | 0.0 | 0 | ||
2007-01-30 | 2006-12-31 | 0.12 | 0.12 | 0.0 | 0 | ||
2006-10-25 | 2006-09-30 | 0.12 | 0.13 | 0.01 | 8 | ||
2006-08-08 | 2006-06-30 | 0.12 | 0.12 | 0.0 | 0 | ||
2006-04-25 | 2006-03-31 | 0.12 | 0.13 | 0.01 | 8 | ||
2006-01-31 | 2005-12-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2005-10-27 | 2005-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2005-08-16 | 2005-06-30 | 0.11 | 0.12 | 0.01 | 9 | ||
2005-04-26 | 2005-03-31 | 0.11 | 0.11 | 0.0 | 0 | ||
2005-02-01 | 2004-12-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2004-10-21 | 2004-09-30 | 0.09 | 0.09 | 0.0 | 0 | ||
2004-08-10 | 2004-06-30 | 0.09 | 0.08 | -0.01 | 11 | ||
2004-04-27 | 2004-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2004-01-27 | 2003-12-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2003-10-23 | 2003-09-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2003-08-12 | 2003-06-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2003-05-01 | 2003-03-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2003-01-28 | 2002-12-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2002-10-25 | 2002-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
2002-08-13 | 2002-06-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2002-04-23 | 2002-03-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2002-01-29 | 2001-12-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2001-10-18 | 2001-09-30 | 0.05 | 0.05 | 0.0 | 0 | ||
2001-08-14 | 2001-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2001-05-01 | 2001-03-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2001-01-30 | 2000-12-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2000-10-24 | 2000-09-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2000-08-15 | 2000-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2000-04-25 | 2000-03-31 | 0.03 | 0.05 | 0.02 | 66 | ||
2000-02-08 | 1999-12-31 | 0.03 | 0.03 | 0.0 | 0 | ||
1999-10-21 | 1999-09-30 | 0.03 | 0.03 | 0.0 | 0 | ||
1999-08-10 | 1999-06-30 | 0.03 | 0.03 | 0.0 | 0 | ||
1999-04-26 | 1999-03-31 | 0.03 | 0.03 | 0.0 | 0 | ||
1999-02-02 | 1998-12-31 | 0.08 | 0.09 | 0.01 | 12 | ||
1998-10-22 | 1998-09-30 | 0.07 | 0.09 | 0.02 | 28 | ||
1998-08-11 | 1998-06-30 | 0.11 | 0.13 | 0.02 | 18 | ||
1998-04-28 | 1998-03-31 | 0.09 | 0.1 | 0.01 | 11 | ||
1998-02-03 | 1997-12-31 | 0.08 | 0.08 | 0.0 | 0 | ||
1997-10-23 | 1997-09-30 | 0.08 | 0.08 | 0.0 | 0 | ||
1997-08-12 | 1997-06-30 | 0.08 | 0.09 | 0.01 | 12 | ||
1997-04-22 | 1997-03-31 | 0.07 | 0.08 | 0.01 | 14 | ||
1997-01-28 | 1996-12-31 | 0.06 | 0.06 | 0.0 | 0 | ||
1996-10-24 | 1996-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
1996-08-15 | 1996-06-30 | 0.07 | 0.07 | 0.0 | 0 | ||
1996-04-22 | 1996-03-31 | 0.06 | 0.07 | 0.01 | 16 |
About Bio Techne Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Bio Techne earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Bio Techne estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Bio Techne fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | 1.5 B | 1.6 B | |
| Retained Earnings Total Equity | 1.5 B | 812.3 M | |
| Earnings Yield | 0.02 | 0.02 | |
| Price Earnings Ratio | 60.46 | 30.92 | |
| Price Earnings To Growth Ratio | (1.89) | (1.80) |
Currently Active Assets on Macroaxis
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.32) | Dividend Share 0.32 | Earnings Share 0.95 | Revenue Per Share | Quarterly Revenue Growth 0.045 |
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.